e-learning
resources
Munich 2006
Sunday 03.09.2006
COPD exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is venous thromboembolism (VTE) a high risk factor in patients with acute exacerbation of CPOD (AECOPD)?
O. M. ElShenawy, S. S. Salama, R. T. Ibrahim, E. M. Abd El-Sameaa, A. A. Mohamed (Assiut, Egypt)
Source:
Annual Congress 2006 - COPD exacerbations
Session:
COPD exacerbations
Session type:
Poster Discussion
Number:
1088
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. M. ElShenawy, S. S. Salama, R. T. Ibrahim, E. M. Abd El-Sameaa, A. A. Mohamed (Assiut, Egypt). Is venous thromboembolism (VTE) a high risk factor in patients with acute exacerbation of CPOD (AECOPD)?. Eur Respir J 2006; 28: Suppl. 50, 1088
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The incidence of venous thromboembolism recurrence in patients after first episode acute pulmonary embolism and related risk factors
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
Presence of inherited risk factors in patients with pulmonary thromboembolism (PTE)
Source: Eur Respir J 2005; 26: Suppl. 49, 521s
Year: 2005
Age is a major risk factor of venous thromboembolism (VTE)
Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism
Year: 2011
Are we screening survivors of acute pulmonary embolism (PE) for chronic thromboembolic pulmonary hypertension (CTEPH)?
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011
Management of acute pulmonary thrombo-embolic disease (PTE) linking mortality risk to treatment strategies
Source: Annual Congress 2009 - Pulmonary circulation II
Year: 2009
Discrimination of acute and chronic pulmonary thromboembolism (PT)
Source: Annual Congress 2007 - Pulmonary circulation
Year: 2007
Thrombophilia in patients with idiopathic pulmonary thromboembolism vs associated with risk factors
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008
Venous thromboembolic (VTE) in patients with ALS: an incidence study
Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes
Year: 2021
Systemic corticosteroids and the risk of venous thromboembolism in COPD patients: A nationwide study of 30.473 outpatients with severe-very severe COPD
Source: Virtual Congress 2021 – Insights into pulmonary embolism
Year: 2021
Patient’s knowledge about risk factors for acute exacerbation( AE ) of chronic obstructive pulmonary disease( COPD )
Source: Eur Respir J 2004; 24: Suppl. 48, 514s
Year: 2004
Venous thromboembolic (VTE) disease in people with chronic obstructive pulmonary disease (COPD): A matched case-control study
Source: International Congress 2015 – New observations in respiratory epidemiology
Year: 2015
Characteristics and prognostic factors associated with cardiovascular (CV) comorbidity in COPD patients hospitalized for acute exacerbation (AECOPD)
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: A risk factor evaluation study
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020
In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Eur Respir J 2005; 26: Suppl. 49, 272s
Year: 2005
Factors associated with survival in patients with not-operated chronic thromboembolic pulmonary hypertension (CTEPH) in the modern management era
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018
Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis?
Source: Eur Respir J 2016; 47: 369-373
Year: 2016
Factors that predict the risk of recurrent venous thromboembolism (VTE) in patients with VTE and factor V Leiden (FVL)
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010
Is it connection between systemic inflammation and risk of thrombotic disorders (by Padua scale) in hospitalized patients with community-acquired pneumonia (CAP)?
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018
The COPD frequency in patients with venous thrombosis
Source: Eur Respir J 2005; 26: Suppl. 49, 57s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept